Title : Correction to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.

Pub. Date : 2021 May

PMID : 33846544






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Correction to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children"s Oncology Group trial AALL0631. lestaurtinib fms related receptor tyrosine kinase 3 Homo sapiens